Dergiler / Turkish journal of nephrology (Online) / 2021 / Cilt: 30 - Sayı: 1

Graft Survival in Preemptive Renal Transplantation in Children

Sayfa
30–36
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Evaluation of graft and patient survival shows that PKT is a safe and effective renal replacement treatment option.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Preemptive kidney transplantation (PKT) is an effective treatment modality that avoids the complications relat ed to dialysis.
📊
Temel Bulgular & Veri:Materials and Methods: The medical records of pediatric kidney transplant recipients between 2005 and 2017 were retro spectively reviewed.
💡
Sonuç & Katkı:Conclusion: Evaluation of graft and patient survival shows that PKT is a safe and effective renal replacement treatment option.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2005 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Preemptive kidney transplantation (PKT) is an effective treatment modality that avoids the complications relat ed to dialysis. However, the effect of PKT on graft survival remains controversial. This study aimed to compare graft survival in pediatric recipients of PKT with that of non-PKT recipients. Materials and Methods: The medical records of pediatric kidney transplant recipients between 2005 and 2017 were retro spectively reviewed. We compared glomerular filtration rate, graft, and patient survival rates receiving PKT versus non-PKT. Results: A total of 230 pediatric recipients were included in the study. The majority of recipients were boys (60.4%) who received a living donor kidney (70.8%). In the study group, 46.1% of the patients underwent PKT; 27.8% were on peritoneal dialysis and 26.1% on hemodialysis in the pre-transplant period. The rates of antibody-mediated rejection and BK virus nephropathy were similar between recipients with PKT and non-PKT (p=1.000 and 0.643, respectively). The 3-year graft and patient survival rates were similar between patients with PKT and non-PKT (95.2% vs 93.5%; p=0.776 and 98.1% vs 97.5%; p=1.000, respectively). The dialysis duration, rejection within 6 months after transplantation, and antibody-mediated rejec tion were independent risk factors for graft failure [Odds ratio (OR) 1.013; 95% confidence interval (CI) 0.992-1.034; p=0.031, OR 0.068; 95% CI 0.105-0.326; p=0.025, and OR 6.029; 95% CI 2.018-7.106; p<0.001]. Conclusion: Evaluation of graft and patient survival shows that PKT is a safe and effective renal replacement treatment option.

🔖

Bu Makaleye Atıf Yap

AKSOY, G. K., KOYUN, M., ÇOMAK, E., AKMAN, S. (2021). Graft Survival in Preemptive Renal Transplantation in Children. Turkish journal of nephrology (Online), Cilt: 30 - Sayı: 1, 30–36. https://ajindex.com/articles/374792

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, et al. Quality of life of children and adolescents with chronic kidney disease: A cross-sectional study. Arch Dis Child 2019
  2. [Crossref] 2. Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: An analysis of the US Renal Data System. JAMA Cardiol 2019
  3. [Crossref] 3. Papalois VE, Moss A, Gillingham KJ, Sutherland DE, Matas AJ, Humar A. Pre-emptive transplants for patients with renal failure: An argument against waiting until dialysis. Transplantation 2000
  4. [Crossref] 4. Debska-Slizień A, Wołyniec W, Chamienia A, Wojnarowski K, Milecka A, Zadrozny D, et al. A single center experience in preemptive kidney transplantation. Transplant Proc 2006
  5. [Crossref] 5. Innocenti GR, Wadei HM, Prieto M, Dean PG, Ramos EJ, Textor S, et al. Preemptive living donor kidney transplantation: Do the benefits extend to all recipients? Transplantation 2007
  6. [Crossref] 6. Pérez-Flores I, Sánchez-Fructuoso A, Calvo N, Marques M, Anaya S, Ridao N, et al. Preemptive kidney transplant from deceased donors: An advantage in relation to reduced waiting list. Transplant Proc 2007
  7. [Crossref] 7. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney International 1996
  8. [Crossref] 8. Fishbane S, Agoritsas S, Bellucci A, Halinski C, Shah HH, Sakhiya V, et al. Augmented nurse care management in CKD stages 4 to 5: A randomized trial. Am J Kidney Dis 2017
  9. [Crossref] 9. Khosla N, Gordon E, Nishi L, Ghossein C. Impact of a chronic kidney disease clinic on preemptive kidney transplantation and transplant wait times. Prog Transplant 2010
  10. [Crossref] 10. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002
  11. [Crossref] 11. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of longterm dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001
  12. [Crossref] 12. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002
  13. [Crossref] 13. Amaral S,